Many vaccines are based around virus-like particles (VLPs). VLPs resemble viruses, but importantly don't carry pathogenic genetic material and thus cannot cause disease. These particles are engineered to display one part of a pathogen to the immune system, which can elicit strong protection upon any subsequent exposure to that pathogen.
Synthetic biologists use bacterial superglue for faster vaccine development
- 20 January 2016
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.